세계의 베스폰사(Besponsa) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Besponsa Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,310,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,121,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,932,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

베스폰사 시장 규모는 향후 몇 년간 강한 성장세를 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 B세포 급성 림프모구 백혈병(ALL)의 유병률 증가, 면역 종양학 및 표적 치료의 발전, 의료 서비스 접근성 개선을 통한 신흥 시장으로의 확장, 맞춤형 및 정밀 의약품에 대한 수요 증가, 지속적인 임상 연구 및 병용 요법의 탐구 등에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 표적 치료의 채택 증가, 새로운 지역으로의 확장, 다른 종양학 의약품과의 병용 요법, 더 광범위한 적응증에 대한 규제 당국의 승인 등이 있습니다.

B세포 급성 림프모구 백혈병(B-ALL)의 발병률이 증가하면서 베스폰사 시장의 성장이 촉진될 것으로 예상됩니다. B-ALL은 유전적 돌연변이, 염색체 이상, 그리고 골수와 혈액에서 미성숙 B세포의 무분별한 증식을 유발하는 환경적 요인이 특징입니다. 표적 치료제인 베스폰사는 암성 B세포의 CD22를 표적으로 하여 백혈병 세포에 직접 화학 요법을 전달하는 동시에 건강한 조직에 대한 손상을 최소화하여 B-ALL 치료에 도움이 됩니다. 따라서 재발성 또는 불응성 사례에 특히 효과적입니다. 예를 들어, 2024년 미국 암 협회는 급성 림프구성 백혈병 신규 환자가 6,550명으로 2023년 6,540명 대비 소폭 증가했다고 보고했습니다. B-ALL의 발생률 증가가 베스폰사 시장 성장을 촉진하고 있습니다.

맞춤형 의약품의 발전이 계속되면 베스폰사 시장이 더욱 활성화될 것으로 예상됩니다. 맞춤형 의약품은 개인의 유전적 구성, 생활 방식 및 환경적 요인에 따라 의료 서비스를 맞춤화하여 치료 효과를 최적화하고 부작용을 최소화합니다. 유전체학 및 생명 공학의 발전으로 더욱 정밀하고 개별화된 치료가 가능해졌습니다. 베스폰사는 CD22 양성 B세포 전구체 급성 림프모구 백혈병(ALL)에 대한 표적 치료를 제공함으로써 맞춤형 의약품에 기여하고 있습니다. 2023년에 FDA는 2022년의 6개에서 16개의 새로운 개인 맞춤형 치료법을 승인하여 이 분야의 상당한 진전을 보였습니다. 베스폰사는 특정 암세포를 표적으로 하는 능력이 개인 맞춤형 의료의 광범위한 동향과 부합하여 시장 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 베스폰사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 베스폰사 시장 : 성장률 분석
• 세계의 베스폰사 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 베스폰사 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 베스폰사 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 베스폰사 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 0.9mg
• 1.0mg
• 세계의 베스폰사 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 급성 림프모구 백혈병
• 비호지킨 림프종
• B세포 전구급성 림프아구성 백혈병
• 화학 요법
• 세계의 베스폰사 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 클리닉
• 재택 케어

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 베스폰사 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 베스폰사 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 베스폰사 시장 : 경쟁 구도
• 베스폰사 시장 : 기업 프로파일
  • Pfizer
  • SFJ Pharmaceuticals Group

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 베스폰사 시장(2029년) : 새로운 기회를 제공하는 국가
• 베스폰사 시장(2029년) : 새로운 기회를 제공하는 부문
• 베스폰사 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Besponsa (inotuzumab ozogamicin) is a monoclonal antibody designed to treat relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). It targets cancerous B-cells, improving treatment efficacy while minimizing damage to healthy tissues. This approach aims to enhance patient survival rates and quality of life.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types in the besponsa market are 0.9 mg and 1.0 mg. The 0.9 mg dosage refers to the specific strength of inotuzumab ozogamicin used in leukemia treatment. Besponsa is applied in the treatment of acute lymphoblastic leukemia, non-Hodgkin lymphoma, B-cell precursor acute lymphoblastic leukemia, and chemotherapy cycles. It is distributed across various end-users, including hospitals, clinics, and homecare settings.

The besponsa market research report is one of a series of new reports from The Business Research Company that provides besponsa market statistics, including besponsa industry global market size, regional shares, competitors with a besponsa market share, detailed besponsa market segments, market trends, and opportunities, and any further data you may need to thrive in the besponsa industry. This besponsa market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The besponsa market size is expected to see strong growth in the next few years. It will grow to $325.4 million in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing prevalence of B-cell acute lymphoblastic leukemia (ALL), advancements in immuno-oncology and targeted therapies, expansion into emerging markets with improving healthcare access, rising demand for personalized and precision medicine, ongoing clinical research and exploration of combination therapies. Major trends in the forecast period include growing adoption of targeted therapies, expansion into new geographies, combination therapies with other oncology drugs, regulatory approvals for broader indications.

The rising incidence of B-cell acute lymphoblastic leukemia (B-ALL) is expected to drive the growth of the besponsa market. B-ALL is characterized by genetic mutations, chromosomal abnormalities, and environmental factors that lead to the uncontrolled growth of immature B-cells in the bone marrow and blood. Besponsa, a targeted therapy, helps treat B-ALL by targeting CD22 on cancerous B-cells, delivering chemotherapy directly to the leukemia cells while minimizing damage to healthy tissue. This makes it particularly effective for relapsed or refractory cases. For example, in 2024, the American Cancer Society reported 6,550 new cases of acute lymphoblastic leukemia, indicating a slight increase from 6,540 cases in 2023. The rising incidence of B-ALL is, therefore, propelling the growth of the besponsa market.

The increasing advancements in personalized medicine are expected to further boost the besponsa market. Personalized medicine tailors healthcare based on an individual's genetic makeup, lifestyle, and environmental factors to optimize treatment efficacy and minimize side effects. Advances in genomics and biotechnology have enabled more precise, individualized treatments. Besponsa contributes to personalized medicine by offering a targeted treatment for CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL). In 2023, the FDA approved 16 new personalized treatments, up from six in 2022, signaling significant progress in this area. Besponsa's ability to target specific cancer cells aligns with the broader trend of personalized healthcare and fuels its market growth.

A key trend in the besponsa market is the development of pediatric-specific formulations of inotuzumab ozogamicin. These are tailored for young patients with relapsed or refractory CD22-positive B-cell precursor ALL, ensuring safety and efficacy for this vulnerable group. For example, in March 2024, Pfizer received FDA approval for Besponsa for the treatment of pediatric patients aged 1 year and older with relapsed or refractory CD22-positive B-ALL. Besponsa is the first and only CD22-directed antibody-drug conjugate approved for this pediatric population, addressing the growing need for effective therapies in children with this life-threatening condition.

Major players operating in the besponsa market are Pfizer, and SFJ Pharmaceuticals Group.

North America was the largest region in the besponsa market in 2024. The regions covered in besponsa report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the besponsa market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The besponsa market consists of sales of lyophilized powder for reconstitution for intravenous infusion. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Besponsa Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on besponsa market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for besponsa ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The besponsa market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 0.9mg; 1.0mg
• 2) By Application: Acute Lymphoblastic Leukemia; Non-Hodgkin Lymphoma; B-Cell Precursor Acute Lymphoblastic Leukemia; Chemotherapy Cycles
• 3) By End-User: Hospitals; Clinics; Homecare Settings
• Companies Mentioned: Pfizer; SFJ Pharmaceuticals Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Besponsa Market Characteristics

3. Besponsa Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Besponsa Market Trends And Strategies

5. Besponsa Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Besponsa Growth Analysis And Strategic Analysis Framework

• 6.1. Global Besponsa PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Besponsa Market Growth Rate Analysis
• 6.4. Global Besponsa Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Besponsa Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Besponsa Total Addressable Market (TAM)

7. Global Besponsa Market Pricing Analysis & Forecasts

8. Besponsa Market Segmentation

• 8.1. Global Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 0.9mg
• 1.0mg
• 8.2. Global Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Lymphoblastic Leukemia
• Non-Hodgkin Lymphoma
• B-Cell Precursor Acute Lymphoblastic Leukemia
• Chemotherapy Cycles
• 8.3. Global Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings

9. Global Besponsa Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Besponsa Market Regional And Country Analysis

• 10.1. Global Besponsa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Besponsa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Besponsa Market

• 11.1. Asia-Pacific Besponsa Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Besponsa Market

• 12.1. China Besponsa Market Overview
• 12.2. China Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Besponsa Market

• 13.1. India Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Besponsa Market

• 14.1. Japan Besponsa Market Overview
• 14.2. Japan Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Besponsa Market

• 15.1. Australia Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Besponsa Market

• 16.1. South Korea Besponsa Market Overview
• 16.2. South Korea Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Besponsa Market

• 17.1. Western Europe Besponsa Market Overview
• 17.2. Western Europe Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Besponsa Market

• 18.1. UK Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Besponsa Market

• 19.1. Germany Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Besponsa Market

• 20.1. France Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Besponsa Market

• 21.1. Eastern Europe Besponsa Market Overview
• 21.2. Eastern Europe Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Besponsa Market

• 22.1. North America Besponsa Market Overview
• 22.2. North America Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Besponsa Market

• 23.1. USA Besponsa Market Overview
• 23.2. USA Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Besponsa Market

• 24.1. Canada Besponsa Market Overview
• 24.2. Canada Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Besponsa Market

• 25.1. South America Besponsa Market Overview
• 25.2. South America Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Besponsa Market

• 26.1. Middle East Besponsa Market Overview
• 26.2. Middle East Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Besponsa Market

• 27.1. Africa Besponsa Market Overview
• 27.2. Africa Besponsa Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Besponsa Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Besponsa Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Besponsa Market Competitive Landscape And Company Profiles

• 28.1. Besponsa Market Competitive Landscape
• 28.2. Besponsa Market Company Profiles
  • 28.2.1. Pfizer Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. SFJ Pharmaceuticals Group Overview, Products and Services, Strategy and Financial Analysis

29. Global Besponsa Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Besponsa Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Besponsa Market

32. Recent Developments In The Besponsa Market

33. Besponsa Market High Potential Countries, Segments and Strategies

• 33.1 Besponsa Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Besponsa Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Besponsa Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료